Oncogene inactivation in a mouse model.
Tanabe
T
T
Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo, Japan.
Kuwabara
T
T
Warashina
M
M
Tani
K
K
Taira
K
K
Asano
S
S
D000494:Allosteric Regulation; D000818:Animals; D017209:Apoptosis; D004195:Disease Models, Animal; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D015316:Genetic Therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017254:Leukemic Infiltration; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D009857:Oncogenes; D016337:RNA, Catalytic / Q000235:genetics / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000378:metabolism; D014407:Tumor Cells, Cultured
D016337:RNA, Catalytic; D012333:RNA, Messenger; D016044:Fusion Proteins, bcr-abl